That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller Journavx, which the Food and Drug Administration approved on ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback